Today: 30 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Praxis Precision Medicines (PRAX) Stock Skyrockets 180% on Game‑Changing Trial – Analysts See ‘Blockbuster’ Upside

Praxis Precision Medicines shares skyrocketed on October 16, 2025, after the biotech reported game-changing Phase 3 trial results for its essential tremor drug. The stock closed that Thursday at $162.71, up over 183% in a single daymedcitynews.com. Earlier that morning, Praxis announced that ulixacaltamide – its experimental therapy for essential tremor – had succeeded in two pivotal late-stage studies. The news sent PRAX stock soaring more than threefold before the opening bellreuters.comreuters.com, smashing its previous highs. By midday, Reuters estimated Praxis was on track to add about $2.67 billion to its market capitalization if gains heldreuters.com. The rally gave the company a market value near $4 billion, up from roughly $1 billion just a day prior. What drove this explosive surge? In a word: breakthrough efficacy. Praxis’s Phase 3 program tested ulixacaltamide in adults with essential tremor – a neurological disorder causing involuntary shaking. In the first trial, ulixacaltamide patients showed a 4.3-point improvement on a standard daily living scale versus placeboglobenewswire.comglobenewswire.com, a highly significant gain. All key secondary endpoints were also metglobenewswire.com, indicating improvements in disease severity and patient and clinician impressions. A second trial used a randomized withdrawal design, and it too succeeded: 55% of those who stayed
17 October 2025
·
CSX CEO Abruptly Departs Amid Rail Merger Frenzy – What’s Next?

CSX Delivers Earnings Surprise: Stock Jumps as New CEO Navigates Rail Merger Frenzy

CSX Corporation delivered stronger-than-expected third quarter results, boosting its stock price in recent trading. Shares of the Jacksonville-based freight railroad rose about 2–3% in after-hours trading following the earnings announcementreuters.com. CSX reported Q3 2025 net earnings of $694 million and an adjusted profit of $0.44 per share, which edged past consensus estimates of roughly $0.42timesunion.comreuters.com. This positive earnings surprise, albeit modest, encouraged investors and helped lift the stock toward the upper-$30s. Revenue for the quarter came in at $3.59 billion, essentially flat and roughly meeting forecastsreuters.com. The railroad managed to offset headwinds in its coal freight business – where low export coal prices dragged sales – by capitalizing on higher intermodal volumes and improved pricing in its merchandise shipping segmentreuters.com. “Our domestic coal business continues to see steady trends through the year,” noted CSX Chief Operating Officer Mike Cory on the earnings call, pointing out that coal demand could rebound as policy shifts encourage more coal productionreuters.com. In the meantime, growth in intermodal shipments and pricing gains in consumer and industrial freight helped stabilize overall revenue.
17 October 2025
····
Interactive Brokers Stock Soars After Q3 Earnings Beat, 40% Asset Surge

Interactive Brokers Stock Soars After Q3 Earnings Beat, 40% Asset Surge

Interactive Brokers Group is making headlines after delivering standout third-quarter results on October 16, 2025, which sent its stock into focus. The online brokerage reported earnings and revenue that topped analyst expectations, fueling optimism among investors. IBKR’s shares closed at $68.52 after the earnings release – marking an impressive rise of about 83% over the past 12 monthsinvesting.com. Below we break down the key facts and expert insights on what’s driving Interactive Brokers’ stock and what may be next. Interactive Brokers’ strong Q3 report initially sparked a positive market reaction, with the stock jumping as much as ~3% in after-hours trading following the October 16 releasegurufocus.com. This uptick reflects optimism that the broker’s earnings power is accelerating. By the next trading day, IBKR shares stabilized in the high-$60s, still near multi-year highs after a stellar run in 2025. The stock has dramatically outperformed benchmarks over the past year, thanks to tailwinds from volatile markets and higher interest rates.
17 October 2025
··
BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA Stock Jumps on Failed Takeover Bid – What’s Next for the Banking Giant?

BBVA’s stock has been on a volatile upswing, with investors closely tracking every development. As of October 16, BBVA shares trade around €15.72 on the Spanish exchange, roughly 0.4% lower on the dayinvesting.com. This slight dip followed a 1.3% drop on Oct. 15investing.com, which erased gains from earlier in the week. Even so, the stock remains near multi-year highs after a strong rally in recent months. The bank’s U.S.-listed ADR closed Oct. 16 at $19.48, leaping about 6.7% from the prior dayinvesting.com. That dramatic one-day jump in New York came as news broke of BBVA’s scuttled acquisition plan – a development traders cheered as removing uncertainty. Trading volumes have surged, reflecting heightened investor interest. On Oct. 16, nearly 9 million BBVA shares changed hands in Madrid – about double the typical daily volumeinvesting.com. In New York, over 6 million ADRs traded, many times the averageinvesting.com. Such volume spikes indicate active institutional trading and momentum investors piling in. Market watchers say the stock’s recent pullback may have presented a buying opportunity. Indeed, technical analysts note BBVA remains in a wide upward channel, and even with recent profit-taking, it’s in the lower band of that rising trend – historically a favorable entry
16 October 2025
··
KKR Stock Plunges 6% Amid Volatility – Analysts See ~25% Upside Ahead

KKR Stock Plunges 6% Amid Volatility – Analysts See ~25% Upside Ahead

KKR’s stock has been on a bumpy ride in recent weeks. On October 16, the private equity giant’s shares plunged nearly 7% intraday, closing around $116reuters.com. That marks a sharp one-day drop amid broader market volatility, as investors have been rotating out of higher-valuation financial stocks in the face of rising interest rates. The latest slide extends a downward trend: KKR is now down about 14% year-to-datets2.tech and roughly 16% lower over the past monthsimplywall.st. By comparison, the S&P 500 is up modestly YTD, and even the financial sector index is up around 12% this yearts2.tech, underscoring KKR’s recent underperformance. Despite the pullback, long-term holders have still seen strong gains – KKR stock had delivered a +179% total return over the past 3 years and +251% over 5 years as of this monthsimplywall.st. But from its lofty 52-week high of ~$170 reached earlier in 2025, KKR has tumbled over 30%reuters.com, reflecting both profit-taking and tempered sentiment toward the alternative asset management sector. The shares currently trade closer to the 52-week low of $86.15 than to the highsreuters.com, indicating a cautious mood among investors.
16 October 2025
·
Visa (V) Stock Poised for a Surge? Crypto Pilot and Travel Deals Fuel Optimism

Visa Stock Slides 3% Despite Fintech Bets – Analysts See Rebound Ahead

Visa’s nearly 3% stock slide on Thursday caught investors’ attention. The drop, which sent shares to ~$335, was steeper than the broader market’s decline and came on the heels of already choppy trading in October. Market analysts attributed the slump partly to general risk-off sentiment – ongoing geopolitical tensions and concerns about banks had U.S. stocks dipping modestly on Oct. 16ts2.tech. However, Visa’s outsized fall suggests company-specific overhangs amplified the move. Traders noted that Visa and other payment stocks have been sensitive to news on regulation and rates, and Thursday’s decline erased roughly $10 from Visa’s share price, putting it near its lowest levels of the year. Despite this pullback, Visa’s stock is still positive for 2025 to date, up high-single-digits percentage-wise. It also remains about 20% higher than it was at this time last yearcompaniesmarketcap.com, thanks to a strong rally in late 2024 and steady gains through mid-2025. Visa’s 52-week range spans roughly $280 to around $375ts2.techts2.tech. Even after the recent dip, shares are well above last year’s lows, reflecting how much Visa recovered as consumer spending rebounded. By comparison, the S&P 500 index is up by a similar mid-single-digit percentage year-to-date, so Visa has roughly tracked the broader
16 October 2025
··
SoFi Stock Skyrockets 230% in 2025 – Will This Fintech Rally Last or Crash?

SoFi Stock Skyrockets Amid Fintech Frenzy – What’s Driving SOFI as Q3 2025 Looms?

SoFi’s stock price has been on a blistering tear in 2025, vastly outperforming the broader market. Shares have surged roughly 230% year-over-year, driven by exploding user growth and improving financial resultsts2.tech. The stock reached a 52-week high of about $30.30 on September 22, 2025, before momentum finally cooled. A subsequent pullback – including seven straight down sessions in early October – brought SOFI down to the mid-$20sts2.tech. By October 16, the stock was hovering around $27 per share, roughly 8–10% below its recent peakts2.tech. Despite this volatility, SOFI remains up over 70% in 2025 and multiples above its year-ago levelsts2.tech, a run that few large-cap stocks can match. The recent dip is widely seen as a “healthy breather” after SoFi’s parabolic risets2.tech. Trading activity has been frenzied – for instance, more than 80 million shares changed hands on October 1ts2.tech – signaling intense interest in the name. Analysts note SoFi’s beta is ~1.9, indicating nearly twice the volatility of the marketts2.tech. In other words, swings in SOFI tend to be amplified, for better or worse. For now, most observers view the stock’s October pullback as a natural consolidation within an ongoing uptrend, rather than the start of any severe reversal.
16 October 2025
··
Uranium Boom Propels Denison Mines (DNN) to New Highs as Analysts Weigh Rally

Uranium Boom Propels Denison Mines (DNN) to New Highs as Analysts Weigh Rally

Toronto, Ontario – October 16, 2025: Denison Mines Corp. is riding a wave of uranium market optimism, with its stock surging to multi-year highs this week. The Canadian uranium developer’s shares have spiked amid soaring uranium prices and a string of positive company milestones. Investors are abuzz over Denison’s progress on key projects and what it means for the future of nuclear energy. Below are the key takeaways from the latest developments: Denison Mines’ U.S.-listed shares have been on a tear in October. The stock is up roughly 15% in the past two weeks alonestockinvest.us, part of a steady climb fueled by bullish uranium sentiment and company-specific news. On Monday, October 13, DNN spiked to an intraday high of $3.14 and finished at $3.05 – marking a new one-year closing highmarketbeat.com. The rally carried into mid-week: on Wednesday the stock oscillated wildly before settling around $3.17stockinvest.us. Such nearly 10% intraday swings underscore the volatility in uranium equities as investors react to fast-changing market dynamics.
16 October 2025
·
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Rigetti’s Quantum Leap: Stock Skyrockets 5,000% Amid Deals & Hype – Bubble or Breakthrough?

Rigetti Computing’s stock has exploded in 2025, reaching new highs as investors bet big on quantum computing. Rigetti’s share price has soared exponentially this year, reflecting frenzy around pure-play quantum computing stocks. At the start of 2025, RGTI traded under $1; by mid-October it rocketed into the mid-$50s, marking a +259% year-to-date gain and roughly 50-fold increase from a year agomarkets.financialcontent.com. The stock closed at a record $56.34 on October 15, 2025macrotrends.net – its highest ever – before settling just below that level. In the span of a few trading days, Rigetti jumped from the mid-$40s to mid-$50s: on Oct. 13 alone, it surged ~25% to $54.91 at closestockinvest.us, and it notched another all-time closing high the following day. This rally has propelled Rigetti’s market capitalization to an eye-popping $16–18 billion rangestockinvest.us, astounding for a company with only single-digit millions in revenue. For context, other quantum computing stocks have also skyrocketed in 2025 – IonQ is up ~700% year-over-year and D-Wave >2,000%ts2.tech – as investors pile into the sector’s promise.
16 October 2025
···
Up 150% YTD: Navitas Semiconductor (NVTS) Rides the GaN Power Wave into AI’s Future

Navitas (NVTS) Stock Hits All-Time High on NVIDIA AI Chip News – Will the Rally Continue?

Navitas shares have been on a tear in mid-October, riding a wave of AI enthusiasm. The stock closed at $15.63 on Oct. 16marketbeat.com, marking its fifth straight daily gain and a new all-time high. In the span of a week, NVTS nearly doubled in price, skyrocketing from the ~$8 level to the mid-$15s. This explosive move caps a year of extraordinary gains – over 330% year-to-date – amid intense investor interest in any company tied to the AI hardware boomfinviz.com. For context, Navitas has vastly outperformed the broader chip indices in 2025, fueled by a series of upbeat announcements and a rush of trading volumets2.tech. Many observers describe the recent price action as a “shoot to orbit” for the once-obscure small-cap stock. What’s driving the surge? In large part, Navitas’s partnership with NVIDIA – revealed in an Oct. 13 press release – has been the catalyst. Navitas unveiled new 100 V GaN power transistors and 650 V GaN/SiC power devices specifically designed to enable NVIDIA’s next-generation 800 V DC data center power architecturets2.tech. NVIDIA has been touting a vision of so-called “AI factories” – massive AI supercomputing data centers that run on 800-volt DC power rails instead of today’s ~54
16 October 2025
··
Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys’ stock surge on Oct. 16 mirrors growing investor interest in its reproductive healthcare pipeline. The company’s FemaSeed™ technology is designed to boost pregnancy rates by delivering sperm directly into the fallopian tube, and published trials report more than double the pregnancy rate of traditional intrauterine inseminationglobenewswire.comstocktitan.net. Femasys is positioning FemaSeed as a first-line, lower-cost infertility option ahead of IVF. Meanwhile, FemBloc offers a first-of-its-kind permanent birth control that creates a natural scar in the fallopian tubes, avoiding surgeryir.femasys.comir.femasys.com. This week’s ASRM announcement – coinciding with broader fertility news – helped lift FEMY. Also on Oct. 16, national media reported an expected US policy to expand IVF access, which analysts say has indirectly boosted Femasys’ profile. By midday on Oct. 16, FEMY was up about 46% at roughly $0.80marketbeat.cominvesting.com.
16 October 2025
··
INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

INVO Fertility (NASDAQ: IVF) Stock Skyrockets 90% as Fertility Boom Fuels Frenzy

INVO Fertility’s stock took investors on a wild ride on Oct. 16, skyrocketing almost 90% by the closing bellreuters.com. Shares opened at just $0.75 and, in an astonishing surge, hit $1.43 by day’s endreuters.com. To put the move in perspective, INVO’s daily gain far outpaced the broader market, and such a jump is highly unusual – even in the volatile biotech sector. Trading volume exploded to over 108 million sharesreuters.com, dwarfing the typical daily volume and exceeding the company’s entire share float many times overreuters.comstocktitan.net. This indicates a tidal wave of speculative interest flooded into the tiny stock. Market observers noted that nothing fundamentally changed overnight with INVO’s business – instead, the price action seems to reflect momentum trading and sector buzz. Notably, short interest was minimalstocktitan.net, so the rally was not a classic short squeeze forcing bears to cover. Rather, it appears traders piled in en masse, perhaps viewing INVO as an ultra-low-priced play on rising fertility trends. Until Oct. 16, INVO had spent most of October drifting around $0.75–0.80 per sharestocktitan.net. The sudden liftoff caught many by surprise – though micro-cap stocks like INVO are known for extreme volatility, and this isn’t the first time INVO has seen
16 October 2025
··
Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Stock Rollercoaster: Earnings Beat, First Brands Fallout & Analyst Forecasts

Jefferies Financial Group’s logo displayed on the trading floor of the New York Stock Exchange. The stock has seesawed amid strong earnings and fallout from a client’s bankruptcy.reuters.comtradingview.com Jefferies’ latest quarterly report showcased robust growth as investment banking activity roared back to life. For Q3, net revenue jumped 21% YoY to $2.05 billionedgen.techedgen.tech. Advisory fees hit a record $656 M, reflecting a surge in mergers & acquisitions – an encouraging sign for Wall Street dealmakersedgen.tech. Equity underwriting revenue leapt 21% to $181 M amid a recovering IPO market, and debt underwriting contributed $249 Medgen.tech. Total investment banking and capital markets revenue climbed ~15% to $1.86 Bedgen.tech.
16 October 2025
···
Costco Stock Surges Amid Retail Gloom – Will $900+ Shares Keep Climbing?

Costco (COST) Stock Slides to ~$924: Analyst Takeaways and Competitor Comparison (Oct 16, 2025)

Key Facts: - Costco shares traded around $924 today, off roughly 3.4% from the prior close of $954.99statmuse.com. - Fiscal Q4 2025 net sales were $84.4 billion and net income $2.61 billioninvestor.costco.cominvestor.costco.com, topping forecasts. - Same-store sales rose 6.4%, slightly above analyst expectationsreuters.com. – Membership fee revenue jumped 14% to $1.72 billionreuters.com. - Wall Street remains broadly bullish: consensus 12‑month price target ~$1,054benzinga.comts2.tech, with most analysts rating COST a “Buy.” - Peers on Oct. 16: Walmart ~105.7 USDinvesting.com, Target ~89.1 USDinvesting.com, BJ’s Wholesale ~94.2 USDinvesting.com. - Economic backdrop: Deloitte projects sluggish holiday retail growth as inflation pressures curb consumer spendingcredaily.com. On Thursday, October 16, 2025, Costco’s stock COST opened around the mid-$950s and slipped to roughly $924 by mid-afternoonstatmuse.com. This marks a roughly 3.4% intraday drop versus Wednesday’s $954.99 closestatmuse.com. The move came as broader retail peers also declined: Walmart fell ~2.6% to $105.67investing.com and Target fell ~1.4% to $89.13investing.com, while smaller rival BJ’s held steady around $94.15investing.com. Stocks in the S&P 500 and retail ETF were also under pressure amid rising bond yields and mixed October data.
16 October 2025
····
Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera (SEV) Nasdaq Debut: Solar EV Startup’s Wild First Day, Key Takeaways and Outlook

Aptera Motors made a splashy entrance onto the Nasdaq Capital Market on October 16, 2025 – and the stock’s first trading day was anything but ordinary. The company’s Class B common shares opened around $20.42 and initially jumped to $22.43, but that early enthusiasm quickly gave way to intense selling pressurekraken.comkraken.com. Within hours, SEV plummeted to an intraday low of $3.63, triggering shock among market watchers at the nearly 80% swing from peak to trough. By midday, the stock had rebounded and stabilized near $9 per share, where it hovered into the afternoonkraken.com. At that price, Aptera’s market capitalization stood at roughly $308 million, a far cry from the unicorn-level valuation some early investors once anticipated. Such extreme volatility is uncommon even for IPOs, and it underscores the uncertain sentiment around Aptera. The company went public via a direct listing, meaning no underwriters set an initial price or provided stabilization – the market was left to determine the value, and it did so in dramatic fashiongurufocus.com. The huge swing suggests that a wave of early shareholders seized the first opportunity to sell, even as other investors jumped in hoping for a piece of the next big EV story. Trading volume
16 October 2025
··
Capital One Savers Cheated Out of Billions – $425M Settlement Payout Deadline Fast Approaching

Capital One Stock Plunges 6% Amid Settlement Showdown, Big Merger & Earnings Countdown

Capital One’s stock has see-sawed in mid-October. It closed at $202.42 on Oct. 16, down 5.9% for the daystockanalysis.com, after a sharp afternoon sell-off. This reversal erased a short rally earlier in the week when COF climbed from ~$202 on Oct. 10 to $215.10 by Oct. 15stockanalysis.com. Traders attribute the sudden drop to a mix of legal headlines and broader bank jitters. Notably, U.S. regional bank stocks also fell ~4% on Oct. 16 amid a credit loss surprise at Zions Bankreuters.comreuters.com, which spooked financial investors sector-wide. Despite this pullback, COF remains up significantly in 2025. As of Oct. 15, shares had gained roughly 22% year-to-datereuters.com【33†L194-L202**, fueled by rising interest income and a blockbuster merger. The stock hit a 52-week high of ~$232 in late September【16†L323-L331】, and is still well above its 52-week low around $143. With the current ~$202 price, COF trades at roughly 8.5× forward earnings, reflecting both low valuation for a growth-driving bank and lingering caution over credit quality.
16 October 2025
····
Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorp Stock Plunges 13% After Surprise $50M Fraud-Linked Loan Loss – Is More Trouble Ahead?

Zions Bancorporation shocked the market this week by revealing a significant credit mishap at its California division. In a late Wednesday 8-K filing, the Salt Lake City-based regional bank disclosed it discovered potential fraud in two related commercial loans totaling about $60 million Investing. After an internal review unearthed “misrepresentations and irregularities” by the borrowers, Zions decided to write off $50 million of the loans and take a provision for the rest, effectively recognizing a total $60 million exposure as likely lost Investing. The bank has already accelerated the loans to default and filed a lawsuit in California against the guarantors in an effort to recover the funds Sec Reuters. “The optics of a large balance C&I loan to a fraudulent borrower from a bank that specializes in small balance C&I loans is not great,” wrote Raymond James analysts, noting the news raises questions about Zions’ risk management and underwriting practices Reuters. Zions primarily serves small and mid-sized businesses across 11 Western and Southwestern states, so a $60 million loan to what appears to be an independent investment fund is outside its usual profile Investing Gurufocus. This may explain why the bank was caught off-guard – the borrowers had attracted
16 October 2025
·
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals

Recursion Pharmaceuticals is a Salt Lake City–based clinical-stage “TechBio” biotech that uses AI, automation and massive biological datasets to speed drug discoveryts2.tech. In early October 2025 the stock showed wild swings: it plunged to the mid-$5s then rebounded ~16% on Oct 8 after an AI-focused tech conference and pipeline newsts2.techts2.tech. As of mid-day Oct 16, RXRX trades around $6.5, having closed at ~$6.79 on Oct 16insidermonkey.com. This volatility reflects renewed investor interest in Recursion’s AI platform and upcoming trial readouts. Recursion’s share price has been unusually volatile in October 2025. On Oct 7 the stock fell about 5.4% to ~$5.23 amid a broader market slidets2.tech. The very next day it surged ~16% to ~$6.08ts2.techts2.tech, likely fueled by investor enthusiasm ahead of CEO Gibson’s AI presentation. By mid-week the rally continued; RXRX closed Oct 16 at $6.79insidermonkey.com. This three-day winning streak was noted by Insider Monkey, which attributed the jump to Gibson’s keynote at a major AI conference in Dubaiinsidermonkey.com.
16 October 2025
·
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue’s stock has been volatile. On Oct 16, 2025 it closed around $15.46, marking a fresh 52-week lowinvesting.com. Over the prior week the shares had slid ~13%, partly driven by jitters over UK talc lawsuits and Trump-era Tylenol claims. Investors bid on options, with call volume surging 52% on Oct 13marketbeat.com, even as the stock dipped 2.9% that day to $16.17marketbeat.com. Year-to-date KVUE is roughly flat to down modestly, but it lags the broader market. For context, the S&P 500 was nearly unchanged while Kenvue was down ~5% on Oct 16. A longer view shows KVUE rose after its 2023 IPO but has struggled through 2024–2025 amid headwinds. Institutionally, Kenvue has a market cap of ~$31 billion and a trailing P/E around 22marketbeat.com. Chart watchers note its 50-day moving average is well above current levelsmarketbeat.com. The sharp recent dips mean many investors wonder if KVUE is “on sale” or if fresh catalysts are needed. The dividend was recently raised to $0.2075 per share, underpinning that 5.1% yieldmarketbeat.com, which helps some income investors tolerate the pullback.
16 October 2025
·
1 … 268 269 270 271 272 … 397

Stock Market Today

  • Maruti Suzuki up 4% after Jefferies upgrade, higher target price
    June 30, 2026, 3:34 AM EDT. Maruti Suzuki India shares rallied almost 4% on June 30 after Jefferies boosted its rating to "Buy" and lifted the price target to Rs 16,500, a call that points to 23% upside. Jefferies said the upgrade was driven by stronger passenger vehicle demand and softer input costs from lower crude and metals. The automaker, which leads the Indian market with a valuation near Rs 4.4 lakh crore, is up 12.6% over the past year against a weak Nifty 50. The brokerage firm also raised EPS estimates for FY27-FY29 and sees 16% CAGR in earnings through FY29. Broader indices Sensex and Nifty slipped, held back by IT, FMCG, metals, and banking stocks, even as Maruti outperformed.
Go toTop